Universal Health Services (UHS) Research

Forward Estimates

EPS Estimates

Current Qtr

$5.89

$5.54$7.17

vs $5.35+10.1%

12 analysts

Next Qtr

$5.61

$5.10$5.95

vs $5.69-1.4%

12 analysts

Current Yr

$23.39

$22.38$25.22

vs $21.74+7.6%

13 analysts

Next Yr

$25.35

$23.81$26.43

vs $23.39+8.4%

13 analysts

Revenue Estimates

Current Qtr

$4.57B

$4.36B$4.79B

vs $4.28B+6.7%

15 analysts

Next Qtr

$4.71B

$4.57B$4.78B

vs $4.50B+4.8%

15 analysts

Current Yr

$18.52B

$17.98B$18.88B

vs $17.36B+6.7%

18 analysts

Next Yr

$19.41B

$18.41B$19.75B

vs $18.52B+4.8%

17 analysts

SEC filings →

View all 10-K, 10-Q, and 8-K filings for UHS on EDGAR.

UHS filing events and research context
Filed	Item	Context
Feb 25, 2026	business	Universal Health Services (UHS) operates a diversified portfolio of acute care and behavioral health facilities across the United States and the United Kingdom. US operations provide comprehensive medical services, including surgery, oncology, and emergency care, while UK operations focus on behavioral health and residential services primarily through National Health Service (NHS) contracts. The company also operates commercial health insurers in Nevada and Puerto Rico, generating revenue through Medicare Advantage premiums and employer group contracts. Financial performance is heavily influenced by government reimbursement complexities. In 2025, UHS realized a $1.283 billion net benefit from state-imposed provider taxes used to increase Medicaid reimbursements. Conversely, the company faces substantial headwinds from uncompensated care, recording $3.9 billion in charity care and uninsured discounts in 2025. Geographic concentration is a key risk, with the Las Vegas market contributing 15% of consolidated net revenues. Additionally, UHS manages significant legal and regulatory exposure, maintaining large self-insurance reserves for professional and general liability. Current material risks include multi-plaintiff litigation regarding the Cumberland Hospital and a $500 million punitive damage verdict in the St. Mary’s Medical Group case, which may impact future capital resources and insurance coverage.
Feb 25, 2026	mda	Universal Health Services (UHS) operates a diversified portfolio of 375 inpatient and 168 outpatient facilities across the U.S., U.K., and Puerto Rico, with net revenues split between acute care (57%) and behavioral health (43%). The U.K. behavioral health segment is a growth driver, generating $1.001 billion in 2025. Significant geographic concentration in Texas, Nevada, and California exposes the company to regional regulatory shifts and climate-related disruptions. A primary financial risk is the One Big Beautiful Budget Act of 2025, which is projected to reduce aggregate annual net Medicaid benefits by $432 million to $480 million by 2032. Operationally, UHS faces persistent clinical staffing shortages and inflationary personnel costs. Legal exposure is substantial, highlighted by the Cumberland Hospital litigation and a significant punitive damage verdict in Nevada. Regarding capital structure, UHS must refinance $700 million in senior notes maturing in September 2026, likely at higher interest rates, while managing a $1.5 billion stock repurchase authorization. The company also maintains a strategic advisory relationship with Universal Health Realty Income Trust, leasing key assets including McAllen Medical Center and Wellington Regional Medical Center.
Feb 25, 2026	risk_factors	UHS faces significant regulatory headwinds, most notably the One Big Beautiful Bill Act of 2025, which introduces Medicaid work requirements and limits provider fees. This legislation is expected to reduce aggregate annual net benefits by $432 million to $480 million by 2032. Further revenue pressure stems from the December 2025 expiration of enhanced premium tax credits and the No Surprises Act's restrictions on out-of-network billing. Operationally, the company is vulnerable to labor shortages and wage inflation, compounded by upcoming June 2026 California staffing standards for acute psychiatric hospitals. Financial risks include the September 2026 maturity of $700 million in senior notes, which will likely be refinanced at significantly higher interest rates. The Loper Bright decision further introduces uncertainty regarding Medicare reimbursement and FDA regulatory interpretations by ending judicial deference to federal agencies. Additionally, UHS is exposed to British pound sterling volatility and potential tariffs on imported pharmaceutical ingredients and medical devices. Market trends toward lower-cost outpatient settings and the heightened risk of ransomware attacks further threaten margins and operational stability. These factors, alongside potential reductions in Medicaid DSH payments starting in 2028, create a complex risk profile for the company's acute and behavioral health segments.

Filed

Item

Context

Feb 25, 2026

business

Universal Health Services (UHS) operates a diversified portfolio of acute care and behavioral health facilities across the United States and the United Kingdom. US operations provide comprehensive medical services, including surgery, oncology, and emergency care, while UK operations focus on behavioral health and residential services primarily through National Health Service (NHS) contracts. The company also operates commercial health insurers in Nevada and Puerto Rico, generating revenue through Medicare Advantage premiums and employer group contracts. Financial performance is heavily influenced by government reimbursement complexities. In 2025, UHS realized a $1.283 billion net benefit from state-imposed provider taxes used to increase Medicaid reimbursements. Conversely, the company faces substantial headwinds from uncompensated care, recording $3.9 billion in charity care and uninsured discounts in 2025. Geographic concentration is a key risk, with the Las Vegas market contributing 15% of consolidated net revenues. Additionally, UHS manages significant legal and regulatory exposure, maintaining large self-insurance reserves for professional and general liability. Current material risks include multi-plaintiff litigation regarding the Cumberland Hospital and a $500 million punitive damage verdict in the St. Mary’s Medical Group case, which may impact future capital resources and insurance coverage.

Feb 25, 2026

mda

Universal Health Services (UHS) operates a diversified portfolio of 375 inpatient and 168 outpatient facilities across the U.S., U.K., and Puerto Rico, with net revenues split between acute care (57%) and behavioral health (43%). The U.K. behavioral health segment is a growth driver, generating $1.001 billion in 2025. Significant geographic concentration in Texas, Nevada, and California exposes the company to regional regulatory shifts and climate-related disruptions. A primary financial risk is the One Big Beautiful Budget Act of 2025, which is projected to reduce aggregate annual net Medicaid benefits by $432 million to $480 million by 2032. Operationally, UHS faces persistent clinical staffing shortages and inflationary personnel costs. Legal exposure is substantial, highlighted by the Cumberland Hospital litigation and a significant punitive damage verdict in Nevada. Regarding capital structure, UHS must refinance $700 million in senior notes maturing in September 2026, likely at higher interest rates, while managing a $1.5 billion stock repurchase authorization. The company also maintains a strategic advisory relationship with Universal Health Realty Income Trust, leasing key assets including McAllen Medical Center and Wellington Regional Medical Center.

Feb 25, 2026

risk_factors

UHS faces significant regulatory headwinds, most notably the One Big Beautiful Bill Act of 2025, which introduces Medicaid work requirements and limits provider fees. This legislation is expected to reduce aggregate annual net benefits by $432 million to $480 million by 2032. Further revenue pressure stems from the December 2025 expiration of enhanced premium tax credits and the No Surprises Act's restrictions on out-of-network billing. Operationally, the company is vulnerable to labor shortages and wage inflation, compounded by upcoming June 2026 California staffing standards for acute psychiatric hospitals. Financial risks include the September 2026 maturity of $700 million in senior notes, which will likely be refinanced at significantly higher interest rates. The Loper Bright decision further introduces uncertainty regarding Medicare reimbursement and FDA regulatory interpretations by ending judicial deference to federal agencies. Additionally, UHS is exposed to British pound sterling volatility and potential tariffs on imported pharmaceutical ingredients and medical devices. Market trends toward lower-cost outpatient settings and the heightened risk of ransomware attacks further threaten margins and operational stability. These factors, alongside potential reductions in Medicaid DSH payments starting in 2028, create a complex risk profile for the company's acute and behavioral health segments.

Forward Estimates

UHS filing events and research context

Keep researching UHS

Related tickers

Related explainers

Forward Estimates